Intravesical immunotherapy with attenuated strains of Mycobacterium bovis is a widely used therapeutic option in patients with non-muscle-invasive transitional cell carcinoma of the bladder. A rare complication of intravesical therapy with the Bacillus Calmette-Guérin vaccine is granulomatous prostatitis, which due to increasing levels of prostate-specific antigen and abnormalities found in transrectal examination of the prostate may suggest concomitant prostate cancer. A case of extensive granulomatous prostatitis in a 61-year-old patient which occurred after the first course of a well-tolerated Bacillus Calmette-Guérin therapy is presented. Due to abnormalities found in rectal examination and an abnormal transrectal ultrasound image of the prostate with extensive infiltration mimicking neoplastic hyperplasia a core biopsy of the prostate was performed. Histopathological examination revealed inflammatory infiltration sites of tuberculosis origin.
Granulomatous prostatitis after intravesical immunotherapy mimicking prostate cancer

Case report
A 61-year-old patient attended a consultation in a urology clinic due to complaints associated with the lower urinary tract. Digital rectal examination (DRE) revealed a slightly enlarged non-painful prostate gland with normal density and smooth contours. Prostate-specific antigen (PSA) level was 2.1 ng/ml. A urine test revealed 10-15 red blood cells/hpf.
The patient reported polyuria during the day and nocturia as well as persistent urgency with a normal urine stream. In an abdominal ultrasound scan no abnormalities were found in the upper urinary tract. Due to the lack of effects of solifenacin therapy the patient was scheduled for a cystoscopy. A 5-millimeter papillomatous lesion was found near the left ureteral orifice. Transurethral en bloc electroresection of the lesion was performed. Samples from the suspicious posterior wall mucosa were also taken.
Histopathological examination of samples from the tumor revealed: "Urothelial carcinoma high-grade pT1, total resection of the lesion". In addition, carcinoma in situ was diagnosed in samples taken from the posterior wall of the urinary bladder. The patient was scheduled for intravesical immunotherapy. Due to the size of the primary lesion (5 mm) and the radicality of the original resection no repeated transurethral electroresection of the tumor of the bladder (re-TURT) was performed.
Bacillus Calmette-Guérin (BCG) vaccine therapy was started 5 weeks after transurethral resection of the tumor (TURT). The vaccine was an attenuated strain of Mycobacterium bovis (Onco BCG 100 formulation, Biofarm, Lublin, Poland, containing at least 300 million live, attenuated mycobacteria of the Brazilian Moreau substrain dissolved in saline in 1 ampoule of 100 mg). An induction course was introduced -6 instillations were administered in weekly intervals. After the first 2 doses the patient reported increases in body temperature of up to 37.5°C as well as urgency episodes.
After 6 weeks from the completion of the induction course cystoscopy and urine cytology were performed and no abnormalities were found.
During a follow-up visit in a urology clinic DRE revealed a very hard non-painful left prostatic lobe with an uneven surface, which was suspected of neoplastic hyperplasia. In line with the European Association of Urology Guidelines (1) , the patient was scheduled for a core biopsy of the prostate based on rectal examination results, despite a low PSA level (2.1 ng/ml in the pre-operative period). In the group of patients with PSA in the range of 2.1-3 ng/ml the risk of prostate cancer diagnosis is 23.9% (European Association of Urology Guidelines) (1) . The biopsy was conducted 3 months after BCG therapy completion.
Twelve samples in total were collected under local anesthesia, including heterogeneously hypoechoic foci located in the peripheral zone on the left side. Histopathological examination revealed multifocal low-grade prostatic intraepithelial neoplasia (LG-PIN) in the right lobe of the
Opis przypadku
Pacjent w wieku 61 lat, konsultowany w poradni urologicznej z powodu dolegliwości z dolnych dróg moczowych. W badaniu DRE (digital rectal examination -przezodbytnicze palpacyjne badanie stercza) stwierdzono nieznacznie powiększony, niebolesny gruczoł krokowy o prawidłowej spoistości i gładkich zarysach. Stężenie PSA (prostate--specific antygen -swoisty antygen sterczowy) 2,1 ng/ml. W analizie moczu erytrocyty 10-15 wpw.
Pacjent zgłaszał częstomocz dzienny i nykturię oraz uporczywe parcia naglące, przy prawidłowym strumieniu moczu. W badaniu USG jamy brzusznej nie stwierdzono nieprawidłowości w zakresie górnych dróg moczowych. Biorąc pod uwagę brak efektów terapii solifenacyną, pacjenta zakwalifikowano do cystoskopii, podczas której znaleziono 5-milimetrową zmianę brodawczakowatą, położoną w okolicy ujścia moczowodu lewego. Wykonano przezcewkową elektroresekcję zmiany, usuwając ją en bloc. Pobrano również wycinki z podejrzanej śluzówki ściany tylnej.
W badaniu histopatologicznym wycinków z guza stwierdzono "Urothelial carcinoma high-grade pT1, zmiana usunięta doszczętnie". Ponadto rozpoznano carcinoma in situ w wycinkach pobranych ze ściany tylnej pęcherza moczowego. Pacjenta zakwalifikowano do immunoterapii dopęcherzo-wej. Ze względu na wielkość zmiany pierwotnej (5 mm) i radykalność resekcji pierwotnej nie wykonano re-TURT (powtórna elektroresekcja przezcewkowa guza pęcherza).
Terapię z użyciem szczepionki BCG (Bacillus Calmette--Guérin), stanowiącej atenuowany szczep Mycobacterium bovis (preparat Onco BCG 100, Biofarm, Lublin, zawierający w 1 amp. 100 mg co najmniej 300 mln żywych, atenuowanych prątków podszczepu brazylijskiego Moreau, rozpuszczonego w soli fizjologicznej), rozpoczęto 5 tygodni po TURT. Zastosowano kurs indukcyjny: 6 wlewek podawanych w odstępach cotygodniowych. Po 2 pierwszych dawkach pacjent zgłaszał zwyżki temperatury ciała do 37,5°C oraz pojawiały się parcia naglące.
Po 6 tygodniach od zakończenia kursu indukcyjnego wykonano cystoskopię oraz badanie cytologiczne moczu, nie stwierdzając nieprawidłowości.
W trakcie wizyty kontrolnej w poradni urologicznej badanie DRE ujawniło, że lewy płat stercza jest bardzo twardy, o nierównej powierzchni, niebolesny, podejrzany o rozrost nowotworowy. Zgodnie z wytycznymi Europejskiego Towarzystwa Urologicznego (European Association of Urology Guidelines) (1) pacjenta zakwalifikowano do biopsji rdzeniowej stercza na podstawie wyniku badania per rectum pomimo niskiego stężenia PSA (2,1 ng/ml w okresie przedoperacyjnym). W grupie pacjentów z PSA w zakresie 2,1-3 ng/ml ryzyko wykrycia raka stercza wynosi 23,9% (European Association of Urology Guidelines) (1) . Biopsję wykonano 3 miesiące po zakończeniu terapii BCG.
Pobrano w znieczuleniu miejscowym łącznie 12 wycinków, uwzględniając ogniska o niejednorodnie obniżonej echoge-Waldemar Białek, Sławomir Rudzki, Paweł Iberszer, Lech Wronecki Granulomatous prostatitis after intravesical immunotherapy mimicking prostate cancer prostate, while prostatitis chronica granulomatosa cum necrosi coagulativa telarum was found in samples from the right lobe, indicating a serious suspicion of tuberculosis origin of the lesions. The patient received consultation in a tuberculosis clinic; however, no indications were found for anti-tuberculosis treatment.
The patient was prescribed with ofloxacin to be taken twice daily for 3 weeks. Eight months after TURT cystoscopy, DRE and TRUS were conducted and samples were taken from lesions with suspected cancer relapse. Rectal examination after 2 months from the biopsy revealed a non-painful, very hard left lobe of the prostate with an uneven surface. TRUS conducted in a reference center revealed an enlarged prostate of 45.6 ml in volume. The peripheral zone on the left, the apex of the prostate in the midline and the area of the membranous urethra on the left were hypoechoic (Fig. 1, 2, 3, 4, 5) . Fine hyperechoic foci with the largest one characterized by reverberations (probably gas) were found (Fig. 6) . Adenomatous enlargement of the transitional and central zones was observed. Seminal vesicles were without abnormalities.
In line with the European Association of Urology Guidelines, due to the presence of a high-grade neoplasm in the original TURT the patient underwent cystoscopy every 3 months. Liquid-based urine cytology was also regularly performed due to the original diagnosis of carcinoma in situ.
In histopathological examination of samples taken during flexible cystoscopy low-grade intraurothelial neoplasia was found in a 1-millimeter sample taken from the neck/left wall Waldemar Białek, Sławomir Rudzki, Paweł Iberszer, Lech Wronecki and posterior wall. A relatively intense chronic inflammatory infiltration with epitheloid cell granuloma was observed in a sample from a polypous mucosa of the prostatic urethra.
In rectal examination performed 9 months after TURT the prostate was very hard on the left side. Transrectal ultrasound scan revealed a peripheral zone on the left side filled with hypoechoic foci with signs of extraprostatic infiltration (Fig. 7, 8) . A core biopsy of the prostate was conducted under neurovascular bundle block. Three samples each were taken bilaterally from the base and four samples each were taken bilaterally from the apex (Fig. 9, 10 ).
The histopathological report stated the following: "Inflammatione chronica partim granulomatosa et cum necrose focali in samples from the base of the left lobe. Inflammatione chronica partim granulomatosa et cum necrose focali in the apex of the left lobe" (Fig. 11) .
During a follow-up visit in a clinic 14 months after TURT rectal examination revealed a very hard, non-painful left lobe of the prostate. The patient did not report complaints associated with the lower urinary tract. Cystoscopy did not reveal any foci with suspected neoplastic hyperplasia. Blood PSA level was 2.4 ng/ml. The result of a liquid-based cytology of urine sediment was negative.
Discussion and conclusions
BCG therapy is currently the most effective immunotherapy method used for the treatment of non-muscle-invasive transitional cell carcinoma of the bladder. Due to the common use of this type of therapy urologists are aware of the most frequent adverse reactions occurring during the therapy, both local and systemic ones (2) . wym wycinku pobranym z szyi/ściany lewej oraz ze ścia-ny tylnej low-grade intraurothelial neoplasia. W wycinku z polipowatej śluzówki cewki sterczowej wykazano dość znacznie nasilony naciek przewlekłego zapalenia z ziarniniakiem nabłonkowatokomórkowym.
W badaniu per rectum wykonanym 9 miesięcy po TURT stercz bardzo twardy po stronie lewej. W USG przezodbytniczym strefa obwodowa po stronie lewej wypełniona przez ogniska hipoechogeniczne, z cechami nacieku pozasterczowego (ryc. 7, 8). W znieczuleniu pęczków naczyniowo-nerwowych wykonano biopsję rdzeniową stercza. Pobrano po trzy wycinki z podstawy obustronnie oraz po cztery wycinki ze szczytu obustronnie (ryc. 9, 10).
W raporcie histopatologicznym podano: w wycinkach z podstawy płata lewego inflammatione chronica partim granulomatosa et cum necrose focali. W szczycie płata lewego inflammatione chronica partim granulomatosa et cum necrose focali (ryc. 11).
Podczas wizyty kontrolnej w poradni 14 miesięcy po podaniu TURT w badaniu per rectum stwierdzono bardzo twardy, niebolesny lewy płat stercza. Pacjent nie zgłaszał dolegliwości z dolnych dróg moczowych. W cystoskopii bez obecności ognisk podejrzanych o rozrost nowotworowy. Stężenie PSA we krwi -2,4 ng/ml. Cytologia osadu moczu LBC (liquid base cytology -metoda cytologii cienkowarstwowej na podłożu płynnym) -ujemna. 
Granulomatous prostatitis after intravesical immunotherapy mimicking prostate cancer
Granulomatous prostatitis of tuberculosis origin is an exceptionally rare complication of intravesical therapy. In approximately 40% of cases an increased PSA level is observed as a result of intravesical instillations (3) . Symptomatic, mycobacterial prostatitis, which requires a 3-month antimycobacterial drug therapy, may be accompanied by symptoms of irritation in the lower urinary tract, pain in the perineum, episodes of hematuria towards the end of micturition, sterile purulent discharge from the urethra and compromised fertility. Histopathological assessment of samples taken from the prostate is recommended if elevated PSA levels persist for more than 3 months. However, no algorithm of optimal treatment has been determined for the cases in which granulomatous prostatitis with little or no symptoms is diagnosed (4) . Immunotherapy should be stopped and antimycobacterial treatment should be considered (5) .
In the present case the patient was referred for a core biopsy of the prostate due to a justified suspicion of concomitant bladder and prostate cancer. In the early follow-up period the presence of a hard or even very hard, non-painful lesion was determined already after an induction course of BCG, while no signs of prostatitis were observed.
Gray-scale, Doppler and elastography ultrasound scans showed a hypoechoic lesion with irregular contours, distinct blood flow and significantly increased density, which did not lose sonographic signs of malignant hyperplasia and even seemed to infiltrate the extraprostatic area despite the discontinuation of the intravesical therapy.
An atypical finding for a prostate ultrasound image were fine hyperechoic foci with reverberation bands dispersed in the hypoechoic lesion, which could have corresponded to necrotic foci found in biopsy specimens.
Omówienie i wnioski
Terapia BCG jest obecnie najskuteczniejszą metodą immunoterapii stosowaną w leczeniu nienaciekającego mięśniówki przejściowonabłonkowego raka pęcherza moczowego. Ze względu na jej powszechne stosowanie urolodzy są świadomi najczęstszych objawów niepożąda-nych towarzyszących terapii, zarówno miejscowych, jak i ogólnych (2) .
Ziarniniakowe zapalenie stercza o podłożu gruźliczym jest wyjątkowo rzadkim powikłaniem immunoterapii dopęche-rzowej. W około 40% przypadków w związku z wlewkami dopęcherzowymi obserwuje się wzrost PSA (3) . Symptomatycznemu, prątkowemu zapaleniu stercza, które wymaga 3-miesięcznej kuracji lekami przeciwprątkowymi, mogą towarzyszyć objawy podrażnieniowe z dolnych dróg moczowych, ból w kroczu, epizody krwiomoczu pod koniec mikcji, jałowy ropny wyciek z cewki moczowej oraz upośledzenie płodności. Zaleca się przeprowadzenie oceny histopatologicznej wycinków ze stercza w przypadku utrzymywania się podwyższonego PSA przez ponad 3 miesiące. Nie ustalono jednak schematu optymalnego leczenia w przypadku stwierdzenia bez-lub skąpoobjawowego ziarniniakowego zapalenia stercza (4) . Należy zakończyć immunoterapię oraz rozważyć leczenie przeciwprątkowe (5) . W opisywanym przypadku kierowano pacjenta na biopsję rdzeniową stercza z powodu uzasadnionego podejrzenia współistnienia raka pęcherza moczowego oraz raka stercza. We wczesnym okresie obserwacji tylko po indukcyj- Unfortunately, transrectal ultrasound imaging does not offer sufficient ability to differentiate between hypoechoic lesions of inflammatory and/or neoplastic nature (6) .
Although rectal examination performed before the instillations demonstrated only enlargement of the prostate that suggested benign, adenomatous hyperplasia, unfortunately, a transrectal ultrasound scan was not performed at the time which could have been the point of reference for images of the prostate obtained after induction BCG therapy. Therefore, in our opinion, not only thorough physical examination, but also imaging of the prostate is justified in patients referred for intravesical therapy, since it allows for comparison of the condition of the prostate with the image from before the therapy.
